NovoLog PenFill Alternatives Compared
| NovoLog PenFill (insulin aspart) | Sodium bicarbonate | Humulin R (insulin regular) |
|
|---|
| NovoLog PenFill (insulin aspart) | Sodium bicarbonate | Humulin R (insulin regular) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Type 2 Diabetes, Diabetic Ketoacidosis, Diabetes - Type 1, Nonketotic Hyperosmolar Syndrome. NovoLog PenFill may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Acidosis, Diabetic Ketoacidosis, Alkylating Agent Cystitis, Asystole, Hyperkalemia, Hyperuricemia Secondary to Chemotherapy, Indigestion, Metabolic Acidosis, Urinary Alkalinization... View more |
Over-the-counter
Prescribed for Type 2 Diabetes, Diabetes - Type 1, Diabetic Ketoacidosis, Gestational Diabetes, Growth Hormone Reserve Test, Hyperkalemia, Insulin Resistance Syndrome, Nonketotic Hyperosmolar... View more |
Related suggestions Diabetic Ketoacidosis
|
|||||||||||||||||||||||
| More about NovoLog PenFill (insulin aspart) | More about Sodium bicarbonate | More about Humulin R (insulin regular) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Sodium bicarbonate has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Humulin R has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all NovoLog PenFill side effects |
View all Sodium bicarbonate side effects |
View all Humulin R side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all NovoLog PenFill prices |
View all Sodium bicarbonate prices |
View all Humulin R prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other insulin aspart brands include: Fiasp, Kirsty, Merilog, Merilog SoloStar, Novolog, NovoLog FlexPen, ReliOn NovoLog | Bell/ans, Neut | Other insulin regular brands include: Humulin R U-500 (Concentrated), Humulin R U-500 KwikPen, Myxredlin, Novolin R, ReliOn/Novolin R | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
1.5 hours |
N/A |
1.5 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 396 drugs are known to interact with NovoLog PenFill:
|
A total of 165 drugs are known to interact with Sodium bicarbonate:
|
A total of 396 drugs are known to interact with Humulin R:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.